Prelude Capital Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Prelude Capital Management’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,314	Closed	-$8.85K	–	2583
2020 Q2	$8K	Buy	+12,314	New	+$9.9K	﹤0.01%	1632
2017 Q3	–	Sell	-14,500	Closed	-$25K	–	1997
2017 Q2	$25K	Buy	14,500 +9,300	+179%	+$19.8K	﹤0.01%	1214
2017 Q1	$14K	Buy	5,200 +4,600	+767%	+$16.5K	﹤0.01%	1325
2016 Q4	$3K	Buy	600 +500	+500%	+$1.65K	﹤0.01%	1480
2016 Q3	$0	Sell	100 -400	-80%	-$920	﹤0.01%	1911
2016 Q2	$1K	Sell	500 -9,489	-95%	-$19.4K	﹤0.01%	1538
2016 Q1	$23K	Buy	+9,989	New	+$22.6K	﹤0.01%	1098
2015 Q4	–	Sell	-2,834	Closed	-$17K	–	1774
2015 Q3	$17K	Buy	+2,834	New	+$19.2K	﹤0.01%	1271

Other funds holding GEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Prelude Capital Management's GEN Position: Q3 2020 in Review

Prelude Capital Management sold out of Genesis Healthcare, Inc. (GEN) in Q3 2020, closing a stake of 12,314 shares — an estimated $8.85K sold.

Prelude Capital Management first reported a position in GEN in Q3 2015 and held it in 8 quarters. The position peaked at $25K in Q2 2017. 55 funds tracked by Wall St. Rank hold GEN as of Q3 2020.

Prelude Capital Management reported no remaining Genesis Healthcare, Inc. position as of Q3 2020 after selling out during the quarter.
Prelude Capital Management sold 12,314 Genesis Healthcare, Inc. shares in Q3 2020, an estimated $8.85K.
Prelude Capital Management first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 8 quarters.
Prelude Capital Management's Genesis Healthcare, Inc. position peaked at $25K in Q2 2017.
55 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.